T10156 |
CCR3 antagonist 1 |
CCR3 antagonist 1 is a potent CCR3 antagonist, used for the research of inflammatory and immunologic diseases. |
T10425 |
AZ084 |
AZ084 is a potent, selective, allosteric, and oral active CCR8 antagonist (Ki: 0.9 nM). It has the potential to treat asthma. |
T10708 |
CCR1 antagonist 6 |
CCR1 antagonist 6 (compound 16q) is a CCR1 antagonist (IC50: 3 nM). |
T10709 |
CCR1 antagonist 7 |
CCR1 antagonist 7 (compound 16r) is a CCR1 antagonist (IC50: 4 nM). |
T10710 |
CCR1 antagonist 9 |
CCR1 antagonist 9 is an effective and selective CCR1 antagonist (IC50: 6.8 nM in calcium flux assay). |
T10711 |
CCR2 antagonist 1 |
CCR2 antagonist 1 is a high-affinity and long-residence-time antagonist of CCR2 (Ki: 2.4 nM). |
T10712 |
CCR2 antagonist 3 |
CCR2 antagonist 3 is a CCR2 antagonist. |
T10714 |
CCR5 antagonist 1 |
CCR5 antagonist 1 is a CCR5 antagonist extracted from WO 2004054974 A2. It can inhibit HIV replication. |
T10756 |
Cenicriviroc Mesylate |
Cenicriviroc Mesylate is a dual CCR2/CCR5 antagonist, also inhibits both HIV-1 and HIV-2 with anti-inflammatory and antiinfective activity. |
T11472L |
Molibresib besylate |
Molibresib besylate is an inhibitor of BET bromodomain (IC50: 32.5-42.5 nM). |
T11521 |
GW 766994 |
GW 766994 is a specific and oral chemokine receptor-3 (CCR3) antagonist. It has the potential for asthma and eosinophilic bronchitis treatment. |
T11699 |
J-113863 |
J-113863 is also a potent antagonist of the human CCR3 (IC50 of 0.58 nM) , but a weak antagonist of the mouse CCR3 (IC50 of 460 nM). J-113863 is inactive agains...
|
T11704 |
JAK-IN-3 |
JAK-IN-3 is a potent JAK inhibitor, with IC50 values of 3 nM, 5 nM, 34 nM and 70 nM for JAK3, JAK1, TYK2 and JAK2, respectively. |
T12076L |
ML218 |
ML218 inhibits the burst activity in the subthalamic nucleus (STN) neurons. ML218 is an effective, selective, and orally active inhibitor of T-type Ca2+ channel...
|
T12419L |
PF-04634817 |
PF-0463481 is safe and well-tolerated and has the potential for the study of diabetic nephropathy. PF-0463481 is an effective and orally active dual CCR2/CCR5 a...
|
T12773 |
RS102895 hydrochloride |
RS102895 hydrochloride is a potent antagonist of CCR2(IC50 of 360 nM). |
T13410 |
ZLDI-8 |
ZLDI-8 is an inhibitor of Notch activating/cleaving enzyme ADAM-17 and inhibits the cleavage of Notch protein. |
T14307 |
Aplaviroc |
Aplaviroc (AK 602), a SDP derivative, is a CCR5 antagonist. With IC50s of 0.1-0.4 nM for HIV-1Ba-L, HIV-1JRFL and HIV-1MOKW. |
T14373 |
AZD2423 |
AZD2423 is a potent, selective, orally bioavailable, and non-competitive CCR2 chemokine receptor negative allosteric modulator and it has an IC50 of 1.2 nM for ...
|
T14688 |
BMS CCR2 22 |
BMS CCR2 22 is a potent, specific and high affinity CC-type chemokine receptor 2 (CCR2) antagonist. It has excellent binding affinity (binding IC50 of 5.1 nM) a...
|
T14899 |
CCR1 antagonist 8 |
CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay). |
T14900 |
CCR2-RA-[R] |
CCR2-RA-[R] is a C-C chemokine receptor type 2 (CCR2) allosteric antagonist (IC50: 103 nM). |
T14909 |
CCX140 |
CCX140 (CCX140-B) is an antagonist of CCR2. |
T15253 |
CCX354 |
CCX354 is a CCR1antagonist. It has anti-inflammatory activity. |
T17274 |
YM022 |
YM022 is a highly effective and selective gastrin/cholecystokinin (CCK)-B receptor antagonist. YM022 can inhibit gastrin-induced gastric acid secretion and hist...
|
T2375 |
BX471 |
BX471 is a potent, selective non-peptide CCR1 antagonist. |
T3188 |
NSC5844 |
NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities. |
T3327 |
Arteether |
Arteether is a new, fast-acting antimalarial drug. |
T3360 |
ZK 756326 |
ZK 756326 is a selective, non-peptide CCR8 chemokine receptor agonist (IC50: 1.8 μM, in human; 2.6 μM, in mouse). Displays no activity at CCR4/5 and CXCR3/4 ...
|
T3430 |
PF4136309 |
INCB8761(PF-4136309) is a specific, effective, and orally bioavailable CCR2 antagonist. |
T3435 |
Vicriviroc maleate |
Vicriviroc maleate(Sch-417690) is a piperazine-based CCR5 receptor antagonist with activity against human immunodeficiency virus. The IC50 value is 0.91 nM in c...
|
T4300 |
AZD2098 |
AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor used for asthma research. |
T4584 |
BMS813160 |
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular. |
T4674 |
SB 297006 |
|
T5384 |
RS 504393 |
RS 504393 is a highly selective CCR2 chemokine receptor antagonist (IC50s: 89 nM and > 100 μM for human recombinant CCR2 and CCR1). |
T6016 |
Maraviroc |
Maraviroc is a C-C Chemokine Receptor Type 5 (CCR5) antagonist, and for MIP-1α(IC50=3.3 nM), MIP-1β (IC50=7.2 nM) and RANTES(IC50=5.2 nM).Maraviroc inhibits H...
|
T6413 |
Bindarit |
Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8. |
T7499 |
TAK-779 |
TAK-779 is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3). |
T7624 |
DAPTA(TFA) |
DAPTA(TFA) is an inhibitor of CCR5, shows potent anti-HIV activities. |
TN2951 |
3-(hydroxymethyl)cyclopentanone |
3-Hydroxymethylcyclopentanone is a precursor to synthesize methyl epijasmonate. 3-Hydroxymethylcyclopentanone compounds, which are useful as intermediates in th...
|
TQ0103 |
INCB3344 |
INCB3344 is an effective, specific and orally bioavailable CCR2 antagonist with IC50 values of 9.5 nM (mCCR2) and 5.1 nM (hCCR2) in binding antagonism and 7.8 n...
|
TQ0182 |
MK-0812 |
MK-0812 is an effective and specific CCR2 antagonist. |
TQ0283 |
RS102895 |
RS102895 is a potent CCR2 antagonist (IC50: 360 nM) and shows no effect on CCR1. |
TQ0297 |
Cenicriviroc |
Cenicriviroc is an orally active, dual antagonist of CCR2/CCR5. It also inhibits both HIV-1 and HIV-2, and displays potent anti-infective and anti-inflammatory ...
|